These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24795107)

  • 1. iTRAQ-based quantitative proteomics study on the neuroprotective effects of extract of Acanthopanax senticosus harm on SH-SY5Y cells overexpressing A53T mutant α-synuclein.
    Li XZ; Zhang SN; Wang KX; Liu SM; Lu F
    Neurochem Int; 2014 Jun; 72():37-47. PubMed ID: 24795107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.
    Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F
    Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral metabonomics study on Parkinson's disease mice treated with extract of Acanthopanax senticosus harms.
    Li XZ; Zhang SN; Lu F; Liu CF; Wang Y; Bai Y; Wang N; Liu SM
    Phytomedicine; 2013 Oct; 20(13):1219-29. PubMed ID: 23830815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acanthopanax senticosus Protects Structure and Function of Mesencephalic Mitochondria in A Mouse Model of Parkinson's Disease.
    Liu SM; Li XZ; Zhang SN; Yang ZM; Wang KX; Lu F; Wang CZ; Yuan CS
    Chin J Integr Med; 2018 Nov; 24(11):835-843. PubMed ID: 30090975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.
    Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J
    Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral potential biomarkers discovery and metabolic pathways analysis of α-synucleinopathies and the dual effects of Acanthopanax senticosus Harms on central nervous system through metabolomics analysis.
    Zhang SN; Li XZ; Lu F; Liu SM
    J Ethnopharmacol; 2015 Apr; 163():264-72. PubMed ID: 25660332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated proteomics and metabolomics reveals metabolism disorders in the α-syn mice and potential therapeutic effect of Acanthopanax senticosus extracts.
    Fu J; Gao X; Lu Y; Lu F; Wang Y; Chen P; Wang C; Yuan C; Liu S
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116878. PubMed ID: 37419226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
    Liu Z; Yu Y; Li X; Ross CA; Smith WW
    Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K.
    Choong CJ; Say YH
    Neurotoxicology; 2011 Dec; 32(6):857-63. PubMed ID: 21658409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of extract of Acanthopanax senticosus Harms on dopaminergic neurons in Parkinson's disease mice.
    Liu SM; Li XZ; Huo Y; Lu F
    Phytomedicine; 2012 May; 19(7):631-8. PubMed ID: 22402244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of wild-type and A53T mutant isoform of alpha-synuclein on the mitochondrial proteome of differentiated SH-SY5Y cells.
    Pennington K; Peng J; Hung CC; Banks RE; Robinson PA
    J Proteome Res; 2010 May; 9(5):2390-401. PubMed ID: 20334438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgolide K promotes the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells.
    Yu W; Chen S; Cao L; Tang J; Xiao W; Xiao B
    Cell Biol Toxicol; 2018 Aug; 34(4):291-303. PubMed ID: 29214369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomics analysis for effect of Acanthopanax senticosus extract on neuroinflammation.
    Jiang T; Wang Z; Shenren ; Xia T; Zhao X; Jiang L; Teng L
    Pak J Pharm Sci; 2015 Jan; 28(1 Suppl):313-8. PubMed ID: 25631509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
    Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray Expression Analysis for the Paradoxical Roles of Acanthopanax senticosus Harms in Treating α-Synucleinopathies.
    Li XZ; Zhang SN; Lu F; Liu SM
    Phytother Res; 2016 Feb; 30(2):243-52. PubMed ID: 26612828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein.
    Zhong J; Li M; Xu J; Dong W; Qin Y; Qiu S; Li X; Wang H
    Toxicol Appl Pharmacol; 2022 Feb; 436():115859. PubMed ID: 34990728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahydroxystilbene glucoside inhibits α-synuclein aggregation and apoptosis in A53T α-synuclein-transfected cells exposed to MPP
    Zhang R; Sun F; Zhang L; Sun X; Li L
    Can J Physiol Pharmacol; 2017 Jun; 95(6):750-758. PubMed ID: 28187263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.
    Melo TQ; van Zomeren KC; Ferrari MF; Boddeke HW; Copray JC
    Exp Brain Res; 2017 Mar; 235(3):731-742. PubMed ID: 27866262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease.
    Xie W; Chung KK
    J Neurochem; 2012 Jul; 122(2):404-14. PubMed ID: 22537068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein interferes with cAMP/PKA-dependent upregulation of dopamine β-hydroxylase and is associated with abnormal adaptive responses to immobilization stress.
    Kim S; Park JM; Moon J; Choi HJ
    Exp Neurol; 2014 Feb; 252():63-74. PubMed ID: 24252179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.